Complementary and alternative medicine use in adults with autism spectrum disorder in Germany: Results from a multi-center survey

BMC Psychiatry

Volumn 19, Issue 1, 2019, Pages

  Höfer, Juliana ^a   Hoffmann, Falk ^a   Kamp Becker, Inge ^b   Küpper, Charlotte ^c   Poustka, Luise ^d   Roepke, Stefan ^c   Roessner, Veit ^e   Stroth, Sanna ^b   Wolff, Nicole ^e   Bachmann, Christian J ^f  

^a UNIVERSITY OF OLDENBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adults; Autism; Autism spectrum disorder; CAM; Complementary and alternative medicine; Germany; Prevalence

Indexed keywords

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ANIMAL ASSISTED THERAPY; ASPERGER SYNDROME; AUTISM; BIOFEEDBACK; CLINICAL EFFECTIVENESS; EVIDENCE BASED MEDICINE; FEMALE; GERMANY; GOLD STANDARD; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT SAFETY; REVIEW; RISK BENEFIT ANALYSIS; YOGA; ADOLESCENT; CLINICAL TRIAL; MULTICENTER STUDY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; YOUNG ADULT;

ACUPUNCTURE THERAPY; ADOLESCENT; ADULT; ANIMAL ASSISTED THERAPY; AUTISM SPECTRUM DISORDER; COMPLEMENTARY THERAPIES; FEMALE; GERMANY; HUMANS; MALE; SURVEYS AND QUESTIONNAIRES; YOGA; YOUNG ADULT;

EID: 85060936148     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-019-2043-5     Document Type: Review

References (54)

1. WHO. Traditional Medicine: Definitions [Internet]. World Health Organization; 2000 [cited 2015 Sep 8]. Available from: http://www.who.int/medicines/areas/traditional/definitions/en/
2. National Center for Complementary and Integrative Health. Complementary, Alternative, or Integrative Health: What's In a Name? [Internet]. 2016. Available from: https://nccih.nih.gov/health/integrative-health
3. Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012:924-39.
4. McFarland B, Bigelow D, Zani B, Newsom J, Kaplan M. Complementary and alternative medicine use in Canada and the United States. Am J Public Health American Public Health Association. 2002;92(10):1616-8.
5. Marstedt G. Moebus S. Inanspruchnahme alternativer Methoden in der Medizin. Robert Koch Institut, Statistisches Bundesamt, editors. Gesundheitsberichterstattung des Bundes H. 2003:9.
6. Millar WJ. Patterns of use - alternative health care practitioners. Heal reports. 2001 Dec;13(1):9-21.
7. Hanssen B, Grimsgaard S, Launsø L, Fønnebø V, Falkenberg T, Rasmussen NK. Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care. 2005 Mar;23(1):57-62.
8. Pedersen CG, Christensen S, Jensen AB, Zachariae R. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer. 2009 Dec;45(18):3172-81.
9. Bahceci B, Bagcioglu E, Ozturk A, Bulbul F, Sahiner IV, Tuncer BE, et al. Complementary and alternative medicine use in patients with mental disorders in Turkey. Complement Ther Clin Pract. 2013 Nov;19(4):221-6.
10. Höfer J, Hoffmann F, Bachmann C. Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: a systematic review. Autism. 2017;21(4):387-402.
11. Feng L, Chiam PC, Kua E-H, Ng TP. Use of complementary and alternative medicines and mental disorders in community-living Asian older adults. Arch Gerontol Geriatr. 50(3):243-9.
12. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;12:1-23.
13. Nilsson J, Källman M, Östlund U, Holgersson G, Bergqvist M, Bergström S. The use of Complementary and alternative medicine in Scandinavia. Anticancer Res. 2016;36(7):3243-51.
14. Metcalfe A, Williams J, McChesney J, Patten SB, Jetté N. Use of complementary and alternative medicine by those with a chronic disease and the general population - results of a national population based survey. BMC Complement Altern Med. 2010;10(1):58.
15. American Psychiatric Association. DSM-V. In: American journal of psychiatry; 2013.
16. Lai M-C, Lombardo MV, Autism B-CS. Lancet. 2014;383(9920):896-910.
17. Brugha TS, McManus S, Bankart J, Scott F, Purdon S, Smith J, et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry. 2011.
18. Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveill Summ. 2018 Apr 27;67(6):1-23.
19. Bachmann CJ, Gerste B, Hoffmann F. Diagnoses of autism spectrum disorders in Germany: time trends in administrative prevalence and diagnostic stability. Autism. 2018;22(3):283-90.
20. Blumberg SJ, Bramlett MD, Kogan MD, Schieve L a, Jones JR, Lu MC. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011- 2012. Natl Health Stat Report 2013;(65):1-12.
21. Kamp-Becker I, Poustka L, Bachmann C, Ehrlich S, Hoffmann F, Kanske P, et al. Study protocol of the ASD-net, the German research consortium for the study of Autism Spectrum disorder across the lifespan: from a better etiological understanding, through valid diagnosis, to more effective health care. BMC psychiatry. BioMed Central. 2017;17(1):206.
22. Jobski K, Höfer J, Hoffmann F, Bachmann C. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatr Scand. 2017 Jan;135(1):8-28.
23. Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, et al. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2018.
24. Gabriels RL, Pan Z, Dechant B, Agnew JA, Brim N, Mesibov G. Randomized controlled trial of therapeutic horseback riding in children and adolescents with Autism Spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(7):541-9.
25. Brondino N, Fusar-Poli L, Rocchetti M, Provenzani U, Barale F, Politi P. Complementary and Alternative Therapies for Autism Spectrum Disorder. Evid based complement Alternat med. Hindawi Limited; 2015;2015:258589.
26. DeFilippis M. The use of Complementary alternative medicine in children and adolescents with Autism Spectrum disorder. Psychopharmacol Bull. 2018;48(1):40-63.
27. Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2015 Jan;24(1):117-43.
28. Bent S, Hendren RL, Zandi T, Law K, Choi J-E, Widjaja F, et al. Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):658-66.
29. Rey JM, Walter G, Soh N. Complementary and alternative medicine (CAM) treatments and pediatric psychopharmocology. J Am Acad Child Adolesc Psychiatry. 2008;47(4):364-8.
30. Bölte S, Rühl D, Schmötzer G, ADI-R PF. Diagnostisches Interview für Autismus - Revidiert. Deutsche Fassung des Autism Diagnostic Interview - Revised von Michael Rutter, Ann Le Couteur und Catherine Lord. 1. Auflage. Bern: Hans Huber; 2006.
31. Rühl D, Bölte S, Feinein-Metthews S, Poustka FADOS. Diagnostische Beobachtungsskala für Autistische Störungen. 1. Auflage. Bern: Hans Huber; 2004.
32. Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, Brewin C, Wing J, editors. Measuring mental health needs. Measuring. London: the Royal College of psychiatrists; 1992. p. 163-83.
33. National Institutes of Health. Complementary and Alternative Medicine [Internet]. U.S. National Library of Medicine; 2003 [cited 2018 Jan 22]. Available from: https://www.nlm.nih.gov/tsd/acquisitions/cdm/subjects24.html
34. UNESCO. International standard classification of education ISCED 1997. Paris: UNESCO; 1997.
35. UNESCO. International Standard. Classification of education ISCED 2011. Montreal: UNESCO Institute for Statistics; 2012.
36. Schroedter JH, Lechert Y, Lüttinger P. Die Umsetzung der Bildungsskala ISCED-1997 für die Volkszählung 1970, die Mikrozensus-Zusatzerhebung 1971 und die Mikrozensen 1976-2004 (Version 1). ZUMA-Methodenbericht, 2006/08. 2011;2006/08:IV,67.
37. Schneider S. The international standard classification of education (ISCED-97): an evaluation of content and criterion validity for 15 European countries. Mannheim: Mannheimer Zentrum fur Europaische Sozialforschung (MZES); 2008. p. 330.
38. Tewes U. HAWIK-R Hamburg-Wechsler-Intelligenztest für Kinder. Revis Bern Huber. 1983.
39. Daseking M, Petermann F, Tewes U, Rossmann P, Schallberger U. Hamburg-Wechsler-Intelligenztest für Kinder III (HAWIK-III). Kindheit und Entwicklung. 2004.
40. Petermann F, Petermann U. Wechsler intelligence scale for children (deutsche Ausgabe) - fourth edition. Frankfurt: Pearson Assessment; 2011.
41. Tewes U. Hamburg-Wechsler-Intelligenztest für Erwachsene. Hawie R, Ed Bern Hans Huber; 1991. 1991
42. Aster M, Neubauer A, Horn R. Wechsler Intelligenztest für Erwachsene WIE. Deutschsprachige Bearbeitung und Adaption des WAIS-III von David Wechsler. Frankfurt/Main, Ger Harcourt Test Serv. 2006
43. Petermann F, Ricken G, Fritz A, Schuck KD, Preuss U. Wechsler preschool and primary scale of intelligence - III - deutsche version. 3rd ed. Frankfurt: Pearson Assessment; 2009.
44. Melchers P, Preuß U. Kaufman assessment battery for children, deutsche version. 8th ed. Frankfurt: Pearson Assessment; 2009.
45. Schmidt K-H, Metzler P. Wortschatztest (WST). Weinheim: Beltz; 1992.
46. Horn R. Standard Progressive Matrices (SPM). (Deutsche Bearbeitung und Normierung nach J. C. Raven.). Frankfurt: Pearson Assessment; 2009.
47. Bullheller S, Matrices HHOCP. (CPM). (Deutsche Bearbeitung und Normierung nach J. C. Raven.). Frankfurt: Pearson Assessment; 2002.
48. Linde K, Alscher A, Friedrichs C, Joos S, Schneider A. The use of complementary and alternative therapies in Germany - a systematic review of nationwide surveys. Forsch Komplementmed. 2014;21(2):111-8.
49. de Jonge P, Wardenaar KJ, Hoenders HR, Evans-Lacko S, Kovess-Masfety V, Aguilar-Gaxiola S, et al. Complementary and alternative medicine contacts by persons with mental disorders in 25 countries: results from the world mental health surveys. Epidemiol Psychiatr Sci. 2017 Dec:1-16.
50. Solomon D, Adams J. The use of complementary and alternative medicine in adults with depressive disorders. A critical integrative review Journal of Affective Disorders. 2015.
51. Wahlström M, Sihvo S, Haukkala A, Kiviruusu O, Pirkola S, Isometsä E. Use of mental health services and complementary and alternative medicine in persons with common mental disorders. Acta Psychiatr Scand. 2008.
52. Höfer J, Bachmann C, Kamp-Becker I, Poustka L, Roessner V, Stroth S, et al. Willingness to try and lifetime use of complementary and alternative medicine in children and adolescents with autism spectrum disorder in Germany: A survey of parents. Autism [Internet]. 2019 Jan 17 [cited 2019 Jan 23];1362361318823545. Available from: http://journals.sagepub.com/doi/10.1177/1362361318823545
53. National Institute for Health and Care Excellence (NICE). Autism spectrum disorder in adults: diagnosis and management | Guidance and guidelines | NICE [Internet]. NICE; [cited 2018 Nov 20]. Available from: https://www.nice.org.uk/guidance/cg142
54. Lindly O, Thorburn S, Heisler K, Reyes N, Zuckerman K. Parent disclosure of complementary health approaches used for children with autism spectrum disorder: barriers and facilitators. Complement Ther Med. 2017 Dec;35:47-52.